Lunai Bioworks, Inc. Deal History & Licensing Activity
Lunai Bioworks, Inc. is a life sciences. Over the past three years, Lunai Bioworks, Inc. has been involved in 2 licensing and acquisition transactions, with a primary focus on Other (4 deals).
Deals (12mo)
2
Active Trials
0
Top Modality
Other
Focus Area
Neurology
Lunai Bioworks, Inc. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Lunai Bioworks, Inc. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Parkinson's disease research collaboration | Lunai Bioworks | Other | Discovery | collaboration | Aug 4, 2026 |
| N2B (nose-to-brain) delivery system | Oncotelic Therapeutics, Inc. | Other | Unknown | license | May 1, 2026 |
Lunai Bioworks, Inc. Pipeline Focus
Therapeutic areas and modalities where Lunai Bioworks, Inc. is most active based on deal history and clinical trial data.
See How Your Asset Matches Lunai Bioworks, Inc.'s Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Neurology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Neurology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for neurology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Lunai Bioworks, Inc. Licensing & Deal Activity
Lunai Bioworks, Inc. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Lunai Bioworks, Inc. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Lunai Bioworks, Inc. include Neurology (4 deals and trials). In terms of modality, Lunai Bioworks, Inc. has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Lunai Bioworks, Inc. and 700+ other biopharma companies. Use our Solidus to benchmark your asset against Lunai Bioworks, Inc.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.